GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tsumura & Co (OTCPK:TSMRF) » Definitions » Current Deferred Revenue

Tsumura (Tsumura) Current Deferred Revenue : $0 Mil (As of Mar. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Tsumura Current Deferred Revenue?

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

Tsumura's current deferred revenue for the quarter that ended in Mar. 2024 was $0 Mil.

Tsumura Current Deferred Revenue Historical Data

The historical data trend for Tsumura's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tsumura Current Deferred Revenue Chart

Tsumura Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Current Deferred Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Tsumura Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Current Deferred Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Tsumura Current Deferred Revenue Related Terms

Thank you for viewing the detailed overview of Tsumura's Current Deferred Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Tsumura (Tsumura) Business Description

Traded in Other Exchanges
Address
2-17-11, Akasaka, Minato-ku, Tokyo, JPN, 107-8521
Tsumura & Co is a specialty and generic drug manufacturing company. The company generates most of its revenue through prescription Kampo products, followed by over-the-counter medicines. Tsumura promotes its products through educational support at medical schools and by hosting seminars for physicians and consumers. The company considers strategic collaboration agreements to be a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Tsumura (Tsumura) Headlines

From GuruFocus

Q2 2020 Tsumura & Co Earnings Presentation Transcript

By GuruFocus Research 02-15-2024